ABSTRACT
Se investigo el efecto del medicamento homeopatico China rubra 9CH en los sintomas reportados por 35 pacientes en la etapa final de insuficiencia renal en hemodialisis regular, en un estudio doble ciego, controlado contra placebo, con fase de observacion y cruzado. Los cambios en el paciente se evaluaron mediante un cuestionario de sintomas. Hay mejorias estadisticamente significativas en cuanto a astenia, letargo y cefaea para el grupo en tratamiento. No hubo cambios significativos en nausea y vomito.
Subject(s)
China officinalis , Renal Dialysis , Asthenia , Renal Insufficiency, ChronicABSTRACT
Se investigo el efecto del medicamento homeopatico China rubra 9CH en los sintomas reportados por 35 pacientes en la etapa final de insuficiencia renal en hemodialisis regular, en un estudio doble ciego, controlado contra placebo, con fase de observacion y cruzado. Los cambios en el paciente se evaluaron mediante un cuestionario de sintomas. Hay mejorias estadisticamente significativas en cuanto a astenia, letargo y cefaea para el grupo en tratamiento. No hubo cambios significativos en nausea y vomito
Subject(s)
China officinalis , Renal Dialysis , Renal Insufficiency, Chronic , AstheniaABSTRACT
The effect of the homoeopathic medicine China rubra 9CH on symptoms reported by 35 patients with end stage renal failure on regular haemodialysis was investigated. The trial was double-blind, placebo-controlled with a run-in phase and crossover. Assessment was by a questionnaire of symptoms. Statistically significant improvements of asthenia, lethargy and headache were detected on active treatment compared to placebo. There was no significant change in nausea and vomiting
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , China officinalis/therapeutic use , Renal Dialysis/adverse effects , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/therapy , Clinical Trials as Topic , Italy , Double-Blind Method , Signs and SymptomsABSTRACT
Taking into account the toxicology of soluble barium salts, the authors treated 32 hypertensive subjects who were confirned to bed in two old people's homes with Baryta carbonica 15 CH versus placebo in a randomized double-blind study. Seventeen patients were given Baryta carbonica and 15 placebo. Taking the groups as a whole, no statistically significant differences were found between the effects of placebo and active drug on the blood pressure. But the four subjects who had been prospectively considered sensitive and were treated with Baryta carbonica gave strongly positive results. Some interesting conclusions were arrived at both from the general medical and the homoeopathic point of view
